Blaise Coleman

Blaise A Coleman currently works at Par Pharmaceutical, Inc., as Chairman, Generics International (US), Inc., as Chairman, Par Pharmaceutical Holdings, Inc., as Chairman, Innoteq, Inc., as Chairman, Par Pharmaceutical Cos., Inc. (New Jersey), as Chairman, Ocugen, Inc., as Director from 2025, Auxilium Pharmaceuticals LLC, as Director, Vintage Pharmaceuticals LLC, as Director, Par Sterile Products LLC, as Director, Slate Pharmaceuticals LLC, as Director, and Endo Innovation Valera LLC, as Director.
Mr. Coleman also formerly worked at BioSpecifics Technologies Corp., as Chairman, President & Chief Executive Officer, Endo International Plc, as President, Chief Executive Officer & Director from 2020 to 2024, Endo, Inc., as President, Chief Executive Officer & Director, AstraZeneca US Investments Ltd., as Senior Director-Commercial Finance, and AstraZeneca AB, as Chief Financial Officer from 2013 to 2015.
Mr. Coleman received his undergraduate degree from Widener University and Masters Business Admin degree from The Fuqua School of Business.